Corrigendum to “Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents”[Eur. J. Med. Chem. 134 (2017) 207–217]>

IF 5.9 2区 医学 Q1 CHEMISTRY, MEDICINAL European Journal of Medicinal Chemistry Pub Date : 2025-02-06 DOI:10.1016/j.ejmech.2025.117329
Yi Gou , Jinlong Li , Boyi Fan , Bohui Xu , Min Zhou , Feng Yang
{"title":"Corrigendum to “Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents”[Eur. J. Med. Chem. 134 (2017) 207–217]>","authors":"Yi Gou , Jinlong Li , Boyi Fan , Bohui Xu , Min Zhou , Feng Yang","doi":"10.1016/j.ejmech.2025.117329","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"287 ","pages":"Article 117329"},"PeriodicalIF":5.9000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425000947","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
“作为潜在抗癌剂的混合配体Cu(II)希夫碱配合物的结构和生物学特性”的勘误表[欧洲]。[j] .中国医学杂志,2017,33 (5):557 - 557
作者对图6B的误用感到遗憾。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
期刊最新文献
Corrigendum to ‘Synthesis and investigation of substituted 1,5-diaryl-1H-1,2,4-triazoles for the discovery of 18F-labeled probes for imaging brain cyclooxygenase-1’ [Eur. J. Med. Chem. 2025, 118523] Optimization of the fragment binding to hinge region for a potent PIM kinase inhibitor based on N-pyridinyl amide scaffold Discovery of potent TNIK inhibitors containing a 1H-pyrrolo[2,3-b]pyridine scaffold as promising therapeutics for colorectal cancer PROTAC-mediated degradation of peroxisomal D-aspartate oxidase: a novel strategy to modulate D-aspartate homeostasis for schizophrenia treatment Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1